Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Financing update

3 Oct 2016 07:00

RNS Number : 4508L
Arria NLG PLC
03 October 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO, OR FROM ANY JURSIDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 ("MAR")

 

 

3 October 2016

 

Arria NLG plc

("Arria NLG" or the "Company")

 

Financing update

 

Arria NLG (AIM: NLG), a world leader in artificial intelligence and natural language generation ("NLG"), is pleased to announce that it has reached agreement with investors, subject to the completion of the relevant documentation, for the subscription of approximately £2.7 million of unsecured convertible loan notes ("Loan Notes") with C warrants attached. The subscribers include existing and new investors in the Company.

 

The terms of the Loan Notes are substantially the same as those announced on 29 June 2015 and in summary the key terms are as follows:

 

· interest at the Bank of England base rate (currently 0.25%) plus 5%, payable in cash, either annually or upon maturity (at the Company's election);

· maturity date of 31 October 2019 with the Company having a right to make repayment before the maturity date; and

· convertible in to new ordinary shares in the Company at a price of 40p per new ordinary share. Loan Note holders are able to convert their Loan Note principal and any unpaid interest into new ordinary shares in the Company shortly before repayment or the maturity date, and annually during a specified window.

 

Subscribers for the Loan Notes will receive two unlisted warrants to subscribe for new ordinary shares in the Company for each US$1.00 invested in the Loan notes, exercisable up to 11 June 2019, at 12p per new ordinary share (the "C Warrants").

 

The proceeds of the issue of Loan Notes will be applied to satisfy the Company's general short term working capital requirements.

 

As previously announced, the Company continues to advance its plans for the listing of the securities of a new New Zealand holding company ("Arria NLG Group") on the main board of the New Zealand Stock Exchange and secondary listings on the Australian Securities Exchange and the standard segment of the Main Market of the London Stock Exchange plc (together, the "Listings"). Further announcements will be made in due course.

 

The Company also advises that under the subscription and sharing agreements between the Company and Lanstead Capital L.P. ("Lanstead"), details of which were announced on 15 October 2015, the monthly payments under the sharing agreements commenced during February 2016 and have continued since. To date the Company has received £1.58 million from Lanstead under the sharing agreements.

 

Sharon Daniels, Chairman and Interim Chief Executive Officer of Arria NLG, commented: "We are very pleased by the support we have received from Lanstead and other existing and new shareholders. The Listing process is progressing and we look forward to providing further details over the coming weeks."

 

 

For further information, please visit www.arria.com or contact:

Arria NLG plc - Chairman and Interim Chief Executive

Sharon Daniels

Tel +44 (0)20 7100 4540

Allenby Capital (Nominated Adviser & Joint Broker)

Nick Naylor

Jeremy Porter

James Reeve

Tel: +44 (0)20 3328 5656

MSL Capital Markets (Lead Manager)

Andrew McDouall

Justine Dunnett

Peter Lynds

Tel: +64 (0)4 472 2716

Stockdale Securities (Joint Broker)

Antonio Bossi

Robert Finlay

Tel: +44 (0)20 7601 6100

IFC Advisory (Financial PR and IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

Tel: +44 (0)20 3053 8671

tim.metcalfe@investor-focus.co.uk

graham.herring@investor-focus.co.uk

heather.armstrong@investor-focus.co.uk

Ruder Finn (PR USA)

Scott Beaver (West Coast)

Brianna Mulligan (East Coast)

 

Tel: +1 541-326-5847

Tel: +1 203-246-1304

 

 

Arria NLG

 

Arria NLG's core product is known as the Arria NLG Platform, a form of artificial intelligence software, specialised in extracting information from complex data sources and communicating that information in natural language (i.e. as if written by a human). The scientific foundation for the Arria NLG Platform is based on more than 30 years of research and development by the Arria|Data2Text Founders at the University of Aberdeen. For additional information, visit www.arria.com. Follow Arria NLG on Twitter, LinkedIn, Google+ and YouTube.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANEAEESKFFF
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.